Curaleaf Holdings (Curaleaf Holdings) Debt-to-Equity : 0.86 (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Curaleaf Holdings Debt-to-Equity?

Curaleaf Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $131 Mil. Curaleaf Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $741 Mil. Curaleaf Holdings's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $1,018 Mil. Curaleaf Holdings's debt to equity for the quarter that ended in Mar. 2024 was 0.86.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Curaleaf Holdings's Debt-to-Equity or its related term are showing as below:

CURLF' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.47 Med: 0.47 Max: 1.18
Current: 0.86

During the past 10 years, the highest Debt-to-Equity Ratio of Curaleaf Holdings was 1.18. The lowest was -0.47. And the median was 0.47.

CURLF's Debt-to-Equity is ranked worse than
81.96% of 848 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs CURLF: 0.86

Curaleaf Holdings Debt-to-Equity Historical Data

The historical data trend for Curaleaf Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curaleaf Holdings Debt-to-Equity Chart

Curaleaf Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.49

0.42

0.43

0.73

0.84

Curaleaf Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.73	0.74	0.81	0.84	0.86

Competitive Comparison of Curaleaf Holdings's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curaleaf Holdings's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Curaleaf Holdings's Debt-to-Equity falls into.

Curaleaf Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Curaleaf Holdings's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(64.899	+	818.648)	/	1050.642
	=	0.84

Curaleaf Holdings's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(130.688	+	740.978)	/	1018.325
	=	0.86

Curaleaf Holdings (OTCPK:CURLF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Curaleaf Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Curaleaf Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Curaleaf Holdings (Curaleaf Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curaleaf Holdings Inc (OTCPK:CURLF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

CURA:Canada

Address

420 Lexington Avenue, Suite 2035, New York, NY, USA, 10170-0052

Website

https://www.curaleaf.com

Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 18 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.